21 September 2021
\n \n \n \nA new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.
\n \n\n \n \n10 September 2021
\n \n \n \nResearchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.
\n \n\n \n \n20 May 2021
\n \n \n \n\n \n \n18 March 2021
\n \n \n \n\n \n \n12 January 2021
\n \n \n \n\n \n \n13 August 2020
\n \n \n \nChanges in the way that neurons communicate with each other affect our ability to move between sleep and wake states.
\n \n\n \n \n27 July 2020
\n \n \n \nProfessor Robert MacLaren is the winner of the Inspiring Leadership category in the Vice-Chancellor's Innovation Awards 2020 for his work on Nightstar, a retinal gene therapy company.
\n \n\n \n \n22 July 2020
\n \n \n \nDPhil student Lampros Bisdounis summarises a departmental seminar by Associate Professor Simon Kyle
\n \n\n \n \n11 June 2020
\n \n \n \nAn international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
\n \n\n \n \n16 May 2020
\n \n \n \nOn the UNESCO International Day of Light, The Daylight Award announce the 2020 Laureates, including Russell Foster who receives the award for his clinical studies in humans addressing important questions regarding light.
\n \n\n \n \n27 April 2020
\n \n \n \nRoyal Society Publishing has recently brought out a special issue of 'Interface Focus' on sleep and stress, past and present
\n \n\n \n \n6 April 2020
\n \n \n \nNHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.
\n \n\n \n \n9 March 2020
\n \n \n \nA group of students got a taste of research at Oxford earlier this month when they spent a day analysing data at our Sleep and Circadian Neuroscience Institute.
\n \n\n \n \n27 February 2020
\n \n \n \nThe results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.
\n \n\n \n \n18 February 2020
\n \n \n \n\u00a3277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.
\n \n\n \n \n10 October 2019
\n \n \n \nDr Kanmin Xue has won the Ruskell Medal from the Worshipful Company of Spectacle Makers
\n \n\n \n \n16 May 2019
\n \n \n \nThe Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows.
\n \n\n \n \n21 March 2019
\n \n \n \nResearchers in our Sleep and Circadian Neuroscience Institute are working with Havant & South Downs College \r\non a teenage sleep study.
\n \n\n \n \n19 February 2019
\n \n \n \nResearchers in Oxford have carried out the world\u2019s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK\u2019s most common cause of sight loss.
\n \n\n \n \n28 January 2019
\n \n \n \nPriya Maharaj has won the Archibald Jackson Prize from Somerville College for achieving a Distinction in the MSc in Sleep Medicine.
\n \n\n \n \n